SEC Form 4 · accession 0001209191-17-025761
Clearside Biomedical, Inc. · CLSD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel H. White
Officer — President and CEO · Director
Period of report
Apr 3, 2017
Accepted (ET)
Apr 5, 2017 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 3, 2017 | S | 3,600 | $7.56 | D | 527,217 | D | |
| Common StockF3 | Apr 4, 2017 | S | 3,600 | $7.54 | D | 523,617 | D | |
| Common StockF2,F4 | Apr 3, 2017 | S | 400 | $7.56 | D | 40,509 | I | By White Family Trust |
| Common StockF3,F4 | Apr 4, 2017 | S | 400 | $7.54 | D | 40,109 | I | By White Family Trust |
| Common StockF5 | holding | — | — | — | 301 | I | As UTMA custodian for son | |
| Common StockF5 | holding | — | — | — | 844 | I | As UTMA custodian for son | |
| Common StockF5 | holding | — | — | — | 1,188 | I | As UTMA custodian for son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the record holders of the securities on March 16, 2017.
- F2This transaction was executed in multiple trades at prices ranging from $7.40 to $7.95, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3This transaction was executed in multiple trades at prices ranging from $7.32 to $7.76, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F4These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F5These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.